Literature DB >> 7837397

[The inhibitory effects of ulinastatin on the increase of interleukin 8 and 6 during open heart surgery].

T Kawamura1, K Inada, O Kimura, N Akasaka, R Wakusawa.   

Abstract

The effects of ulinastatin on the serum interleukin 8 and 6 (IL-8, 6), granulocyte elastase (GEL), creatinphosphokinase (CK) and CK-MB were studied during open heart surgery under cardiopulmonary bypass (CPB). Eleven patients (group I) did not receive ulinastatin. Thirteen patients (group II) received 600,000 units of ulinastatin intravenously before CPB and before declamping of aorta and 12 patients (group III) received 300,000 units more added in the priming solution. The serum concentration of IL-8 and 6 increased at 60, 120, 180 min. after reperfusion compared with the preoperative value in the three groups. But, at each time point after reperfusion, IL-8 and 6 levels in group II and III were significantly lower (P < 0.01) than those in group I. GEL increased progressively after reperfusion in the three groups. There was no significant difference in the three groups with CK-MB as well CK release. These results suggest that ulinastatin is useful for protection of reperfusion injury after myocardial ischemia since ulinastatin suppresses production of IL-8 and 6.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7837397

Source DB:  PubMed          Journal:  Masui        ISSN: 0021-4892


  5 in total

1.  Ulinastatin reduces elevation of cytokines and soluble adhesion molecules during cardiac surgery.

Authors:  T Kawamura; K Inada; N Akasaka; R Wakusawa
Journal:  Can J Anaesth       Date:  1996-05       Impact factor: 5.063

2.  Effects of a protease inhibitor, ulinastatin, on coagulation and fibrinolysis in abdominal surgery.

Authors:  Tomoki Nishiyama; Takeshi Yokoyama; Koichi Yamashita
Journal:  J Anesth       Date:  2006       Impact factor: 2.078

3.  Endothelial Glycocalyx Layer: A Possible Therapeutic Target for Acute Lung Injury during Lung Resection.

Authors:  JiaWan Wang; AnShi Wu; Yan Wu
Journal:  Biomed Res Int       Date:  2017-12-20       Impact factor: 3.411

4.  Effects of Ulinastatin on Myocardial Ischemia-Reperfusion Injury, Cardiac Function, and Serum TNF-α and IL-10 Levels in Patients Undergoing Cardiac Valve Replacement under Cardiopulmonary Bypass.

Authors:  Hai Wang; Dafa Zhang; Hongbo Qian; Jun Nie; Jun Wei
Journal:  Comput Math Methods Med       Date:  2022-04-01       Impact factor: 2.238

Review 5.  Does intraoperative ulinastatin improve postoperative clinical outcomes in patients undergoing cardiac surgery: a meta-analysis of randomized controlled trials.

Authors:  Qiu-Lan He; Fei Zhong; Fang Ye; Ming Wei; Wei-Feng Liu; Mei-Na Li; Qiao-Bo Li; Wen-Qi Huang; Lai-Bao Sun; Hai-Hua Shu
Journal:  Biomed Res Int       Date:  2014-03-09       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.